437 related articles for article (PubMed ID: 3805869)
1. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
2. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
4. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
[TBL] [Abstract][Full Text] [Related]
5. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
[TBL] [Abstract][Full Text] [Related]
6. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
Robbins RA; Hamel FG
J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
[TBL] [Abstract][Full Text] [Related]
9. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
13. Role of chemotactic factor inactivation in neutrophil chemotaxis.
Tannous R; Cavender-Zylich N; Ginsberg BH
J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
[TBL] [Abstract][Full Text] [Related]
14. Human alveolar macrophages release a factor that inhibits phagocyte function.
Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
[TBL] [Abstract][Full Text] [Related]
15. Elevation of chemotactic factor inactivator in alcoholic liver disease.
Robbins RA; Zetterman RK; Kendall TJ; Gossman GL; Monsour HP; Rennard SI
Hepatology; 1987; 7(5):872-7. PubMed ID: 3653852
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
Webster RO; Goldstein IM; Flick MR
J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
18. Complement fragments, alveolar macrophages, and alveolitis.
Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
[TBL] [Abstract][Full Text] [Related]
19. Porcine spermadhesin PSP-I/PSP-II stimulates macrophages to release a neutrophil chemotactic substance: modulation by mast cells.
Assreuy AM; Alencar NM; Cavada BS; Rocha-Filho DR; Feitosa RF; Cunha FQ; Calvete JJ; Ribeiro RA
Biol Reprod; 2003 May; 68(5):1836-41. PubMed ID: 12606406
[TBL] [Abstract][Full Text] [Related]
20. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
